The costs of respiratory testing increased over time, from a low of $21 million in 2016 to a high of $111 million in 2022.
Pandemic ushered in costly increase in testing for respiratory pathogens, study finds
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- US flu ebbs for third straight week, but impact on healthcare remains
- 1 in 5 men surveyed had erectile dysfunction up to 2 years after COVID
- Genetic vulnerability, air pollution may raise risk of COVID infection, severe outcomes
- COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal